FDA 483 - Bloodworks - May 03, 2024
FDA 483 for Bloodworks on May 03, 2024. Product: biologics. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA 483 for Bloodworks on May 03, 2024. Product: biologics. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
BloodworksInspection Date
May 3, 2024
Product Type
biologics
ID: 80a76998-4c87-4acc-b8ac-fc1e05a43565
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox